Photo Rounds

Generalized pruritic blisters and bullous lesions

Author and Disclosure Information

 

References

Risk factors for BP. Certain conditions linked to developing BP include neurologic disorders (dementia and Parkinson disease) and psychiatric disorders (unipolar and bipolar disorder).4 Further, it is important to note any medications that could be the cause of a patient’s BP, including dipeptidyl peptidase-4 (DPP-4) inhibitors, psychotropic medications, spironolactone, furosemide, beta-blockers, and antibiotics.3 This patient was taking a beta-blocker (metoprolol) and a DPP-4 inhibitor (linagliptin). Because he was most recently started on linagliptin, we suspected it may have had a causal role in the development of BP.

The association of DPP-4 inhibitors and BP

FPs are increasingly using DPP-4 inhibitors—including sitagliptin, vildagliptin, and linagliptin—as oral antihyperglycemic agents for type 2 diabetes mellitus. Therefore, it’s important to recognize this medication class’s association with BP.5 In a case-control study of 165 patients with BP, Benzaquen et al reported that 28 patients who were taking DPP-4 inhibitors had an associated increased risk for BP (adjusted odds ratio = 2.64; 95% confidence interval [CI], 1.19-5.85).3

The pathophysiology of BP associated with DPP-4 inhibitors remains unclear, but mechanisms have been proposed. The DPP-4 enzyme is expressed on many cells, including keratinocytes, T cells, and endothelial cells.3 It is possible that DPP-4 inhibition at these cells could stimulate activity of inflammatory cytokines, which can lead to enhanced local eosinophil activation and trigger bullous formation. DPP-4 enzymes are also involved in forming plasmin, which is a protease that cleaves BP180.3 Inhibition of this process can affect proper cleavage of BP180, impacting its function and antigenicity.3,6

Other conditions that also exhibit blisters

There are some skin conditions with similar presentations that need to be ruled out in the work-up.

Bullous diabeticorum is a rare, spontaneous, noninflammatory condition found in patients with diabetes.1 Blisters usually manifest as large, tense, asymmetrical, mildly tender lesions that commonly affect the feet and lower legs but can involve the trunk. These usually develop overnight without preceding trauma. Biopsy would show both intra-­epidermal and subepidermal bulla with normal DIF findings.1 This condition usually has an excellent prognosis.

Continue to: Pemphigus vulgaris

Pages

Recommended Reading

Large study links brown fat with lower rates of cardiometabolic disease
MDedge Family Medicine
Another lot of extended-release metformin is recalled in the U.S.
MDedge Family Medicine
Endocrine Society calls for action to reduce insulin costs
MDedge Family Medicine
To fast or not? The new dieting dilemma
MDedge Family Medicine
Pressure builds on CDC to prioritize both diabetes types for vaccine
MDedge Family Medicine
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
MDedge Family Medicine
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
MDedge Family Medicine
Low-carb diets boost diabetes remission rates, at least short term
MDedge Family Medicine
Tactics to prevent or slow progression of CKD in patients with diabetes
MDedge Family Medicine
Can viscous fiber lower glycemic markers in type 2 diabetes?
MDedge Family Medicine